Medtronic (MDT) yesterday announced the launch of its Penditure Left Atrial Appendage Exclusion System in the United States. The Penditure LAA Exclusion System is an innovative, implantable clip that comes pre-loaded on a single-use delivery system for use in left atrial appendage management during concomitant cardiac surgery procedures. The Penditure clip is curved to better match the atrial anatomy and was designed without fabric for atraumatic closure and reduced inflammation. The Penditure device is the only LAA clip that can be recaptured, repositioned, and redeployed after deployment during a procedure, putting greater control in the hands of surgeons. According to MedTech Dive’s Susan Kelly, the device is the newest challenger to Boston Scientific’s (BSX) Watchman in a broadening market that also includes Abbott’s (ABT) Amplatzer Amulet treatment and AtriCure (ATRC).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MDT:
- Medtronic price target lowered to $98 from $104 at Morgan Stanley
- Medtronic price target raised to $84 from $78 at Truist
- Medtronic price target raised to $84 from $77 at Baird
- Early notable gainers among liquid option names on November 21st
- Medtronic sees Q3 organic revenue growth 4%-4.5%
Questions or Comments about the article? Write to editor@tipranks.com